Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram Combined With Cisplatin for Advanced Gastric Cancer
NCT05667415Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of disulfiram in gastric cancer (GC) (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoints: Complete Response, Partial Response and 2 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
disulfiram
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05667415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667415.